Subtitle
Outcome after Radiotherapy for Vestibular Schwannomas – Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.
Subtitle
Outcome after Radiotherapy for Vestibular Schwannomas – Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy.
Proto therapy Time
April 2022
Executive summary
Based on the data of 261 patients with VS treated with stereotactic radiosurgery/hypofractionated stereotactic radiotherapy (SRS/HFSRT), this study reported at 12 months LC of 99.5% and the hearing preservation rate of 97% with no statistical difference among the groups. The authors concluded that SRS/HFSRT, FRT and FPT for VS showed similar overall clinical and functional outcomes.
Key content topics
Top cancer treatments
Related contents
Proton Therapy Publication
March 2024
A multicenter high-quality data registry for advanced proton therapy approaches: the POWER registry.
Webinar
March 29, 2023
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
Roberto
Orecchia
Barbara
Jereczek
Daniela
Alterio
Dante
Amelio
Jiri
Kubes
Proton Therapy Publication
March 2023
A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Proton Therapy Publication
November 2022
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
Proton Therapy Publication
May 2022
The Role of Hypofractionation in Proton Therapy.
Proton Therapy Publication
December 2021
FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification.
Proton Therapy Publication
November 2021
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.
Proton Therapy Publication
November 2021
Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy.
Webinar
September 18, 2021
PTCOG NA Symposium: hypofractionation and SBRT with proton therapy
Swati
Girdhani
Ramesh
Rengan
Jing
Zeng